SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    David H. Adams, Alberto Sanchez-Fueyo, Didier Samuel, From immunosuppression to tolerance, Journal of Hepatology, 2015, 62, 1, S170

    CrossRef

  2. 2
    J. G. O'Leary, H. Kaneku, N. Banuelos, L. W. Jennings, G. B. Klintmalm, P. I. Terasaki, Impact of IgG3 Subclass and C1q-Fixing Donor-Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation, American Journal of Transplantation, 2015, 15, 4
  3. 3
    Antal Dezsőfi, Ulrich Baumann, Anil Dhawan, Ozlem Durmaz, Björn Fischler, Nedim Hadzic, Loreto Hierro, Florence Lacaille, Valérie A. McLin, Valerio Nobili, Piotr Socha, Pietro Vajro, Alexander S. Knisely, Liver Biopsy in Children, Journal of Pediatric Gastroenterology and Nutrition, 2015, 60, 3, 408

    CrossRef

  4. 4
    C.K. Burghuber, T.K. Roberts, S.J. Knechtle, The clinical relevance of alloantibody in liver transplantation, Transplantation Reviews, 2015, 29, 1, 16

    CrossRef

  5. 5
    Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi, Transplantation of the Liver, 2015,

    CrossRef

  6. 6
    Wulamujiang Aini, Aya Miyagawa-Hayashino, Munetaka Ozeki, Salah Adeeb, Masahiro Hirata, Keiji Tamaki, Shinji Uemoto, Hironori Haga, Accelerated telomere reduction and hepatocyte senescence in tolerated human liver allografts, Transplant Immunology, 2014, 31, 2, 55

    CrossRef

  7. 7
    Timucin Taner, Mark D. Stegall, Julie K. Heimbach, Antibody-mediated rejection in liver transplantation: Current controversies and future directions, Liver Transplantation, 2014, 20, 5
  8. 8
    Adeeb Salah, Masakazu Fujimoto, Atsushi Yoshizawa, Kimiko Yurugi, Aya Miyagawa-Hayashino, Shinji Sumiyoshi, Sachiko Minamiguchi, Shinji Uemoto, Taira Maekawa, Hironori Haga, Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation, Liver Transplantation, 2014, 20, 2
  9. 9
    Hidenori Ohe, Yoichiro Uchida, Atsushi Yoshizawa, Hirofumi Hirao, Michiko Taniguchi, Etsuko Maruya, Kimiko Yurugi, Rie Hishida, Taira Maekawa, Shinji Uemoto, Paul I. Terasaki, Association of Anti-Human Leukocyte Antigen and Anti-Angiotensin II Type 1 Receptor Antibodies With Liver Allograft Fibrosis After Immunosuppression Withdrawal, Transplantation, 2014, 98, 10, 1105

    CrossRef

  10. 10
    Jacqueline G. O'Leary, Hugo Kaneku, Linda Jennings, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients, Liver Transplantation, 2014, 20, 6
  11. 11
    C. Venturi, C. Sempoux, J. A. Quinones, C. Bourdeaux, S. P. Hoyos, E. Sokal, R. Reding, Dynamics of Allograft Fibrosis in Pediatric Liver Transplantation, American Journal of Transplantation, 2014, 14, 7
  12. 12
    Taizen Urahashi, Koichi Mizuta, Yoshiyuki Ihara, Yukihiro Sanada, Taiichi Wakiya, Naoya Yamada, Noriki Okada, Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation, Transplant International, 2014, 27, 3
  13. 13
    Arnaud Del Bello, Nicolas Congy-Jolivet, Lionel Rostaing, Nassim Kamar, Incidence of anti-HLA donor specific antibodies in liver-transplant patients given mTOR inhibitors without calcineurin inhibitors, Journal of Hepatology, 2014, 61, 4, 963

    CrossRef

  14. 14
    A. Del Bello, N. Congy-Jolivet, F. Muscari, L. Lavayssière, L. Esposito, I. Cardeau-Desangles, J. Guitard, G. Dörr, B. Suc, J. P. Duffas, L. Alric, C. Bureau, M. Danjoux, C. Guilbeau-Frugier, A. Blancher, L. Rostaing, N. Kamar, Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant Patients, American Journal of Transplantation, 2014, 14, 4
  15. 15
    J. G. O'Leary, A. J. Demetris, L. S. Friedman, H. M. Gebel, P. F. Halloran, A. D. Kirk, S. J. Knechtle, S. V. McDiarmid, A. Shaked, P. I. Terasaki, K. J. Tinckam, S. J. Tomlanovich, K. J. Wood, E. S. Woodle, A. A. Zachary, G. B. Klintmalm, The Role of Donor-Specific HLA Alloantibodies in Liver Transplantation, American Journal of Transplantation, 2014, 14, 4
  16. 16
    Hirofumi Tomita, Ken Hoshino, Yasushi Fuchimoto, Hirotoshi Ebinuma, Kiyoshi Ohkuma, Yutaka Tanami, Wenlin Du, Yohei Masugi, Naoki Shimojima, Akihiro Fujino, Motohiro Kano, Takumi Fujimura, Hideo Ishihama, Takahiro Shimizu, Minoru Tanabe, Hidetsugu Saito, Michiie Sakamoto, Toshifumi Hibi, Yuko Kitagawa, Tatsuo Kuroda, Acoustic radiation force impulse imaging for assessing graft fibrosis after pediatric living donor liver transplantation: A pilot study, Liver Transplantation, 2013, 19, 11
  17. 17
    Patricia Campbell, Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation, Current Opinion in Organ Transplantation, 2013, 18, 4, 463

    CrossRef

  18. 18
    H. Kaneku, J. G. O'Leary, N. Banuelos, L. W. Jennings, B. M. Susskind, G. B. Klintmalm, P. I. Terasaki, De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients, American Journal of Transplantation, 2013, 13, 6
  19. 19
    H. Kaneku, J. G. O'Leary, N. Banuelos, L. W. Jennings, B. M. Susskind, G. B. Klintmalm, P. I. Terasaki, De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients, American Journal of Transplantation, 2013, n/a

    CrossRef

  20. 20
    Martina Koch, Christian Gräser, Anja Lehnhardt, Jörg M. Pollok, Nikolaus Kröger, Murielle Verboom, Friedrich Thaiss, Thomas Eiermann, Björn Nashan, Four-year allograft survival in a highly sensitized combined liver–kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib, Transplant International, 2013, 26, 8
  21. 21
    Jacqueline G. O’Leary, Göran B. Klintmalm, Impact of donor-specific antibodies on results of liver transplantation, Current Opinion in Organ Transplantation, 2013, 18, 3, 279

    CrossRef

  22. 22
    Jacqueline G. O'Leary, Hugo Kaneku, Linda W. Jennings, Nubia Bañuelos, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation, Liver Transplantation, 2013, 19, 9
  23. 23
    Alexandru I. Musat, Courtney M. Pigott, Thomas M. Ellis, Rashmi M. Agni, Glen E. Leverson, Amy J. Powell, Katelyn R. Richards, Anthony M. D'Alessandro, Michael R. Lucey, Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation, Liver Transplantation, 2013, 19, 10
  24. 24
    Anthony J. Demetris, Kumiko Isse, Tissue biopsy monitoring of operational tolerance in liver allograft recipients, Current Opinion in Organ Transplantation, 2013, 18, 3, 345

    CrossRef